Company profile for Novocellbio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a company that researches and develops autoimmune cell therapy products using NK immune cells. It is a Korean biotechnology company that possesses NK cell culture technology, which is essential for the treatment of various cancers and autoimmune diseases. Immune cell therapy is one of the most active drugs in the biotechnology market. It is a next-generation anticancer drug and autoimmune disease drug, and its growth...
We are a company that researches and develops autoimmune cell therapy products using NK immune cells. It is a Korean biotechnology company that possesses NK cell culture technology, which is essential for the treatment of various cancers and autoimmune diseases. Immune cell therapy is one of the most active drugs in the biotechnology market. It is a next-generation anticancer drug and autoimmune disease drug, and its growth potential is endless. Especially, NK cells in immune cells have excellent ability to treat diseases, but bio-industry's judgment is that it is not easy to develop effective therapeutic agents.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
8F. Aniocean B/D, 99 Incheontower-daero, Yeonsu-gu, Incheon
Telephone
Telephone
82-32-723-9988
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty